These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1115 related items for PubMed ID: 14513366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation.
    Xie X, He G, Siddik ZH.
    Mol Cancer Res; 2017 Mar; 15(3):328-339. PubMed ID: 28031409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints.
    Kuang J, He G, Huang Z, Khokhar AR, Siddik ZH.
    Clin Cancer Res; 2001 Nov; 7(11):3629-39. PubMed ID: 11705886
    [Abstract] [Full Text] [Related]

  • 9. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME, Blok P, Offerhaus GJ, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SG.
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [Abstract] [Full Text] [Related]

  • 10. Prolonged wild-type p53 protein accumulation and cisplatin resistance.
    Yazlovitskaya EM, DeHaan RD, Persons DL.
    Biochem Biophys Res Commun; 2001 May 18; 283(4):732-7. PubMed ID: 11350044
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K, Li Z, Seth P, Cowan KH, Sinha BK.
    Oncol Res; 1997 May 18; 9(11-12):603-9. PubMed ID: 9563008
    [Abstract] [Full Text] [Related]

  • 14. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
    Sánchez-Beato M, Piris MA, Martínez-Montero JC, García JF, Villuendas R, García FJ, Orradre JL, Martínez P.
    J Pathol; 1996 Sep 18; 180(1):58-64. PubMed ID: 8943816
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
    Burch LR, Scott M, Pohler E, Meek D, Hupp T.
    J Mol Biol; 2004 Mar 12; 337(1):115-28. PubMed ID: 15001356
    [Abstract] [Full Text] [Related]

  • 17. Cisplatinum and taxol induce different patterns of p53 phosphorylation.
    Damia G, Filiberti L, Vikhanskaya F, Carrassa L, Taya Y, D'incalci M, Broggini M.
    Neoplasia; 2001 Mar 12; 3(1):10-6. PubMed ID: 11326311
    [Abstract] [Full Text] [Related]

  • 18. Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.
    Akimoto T, Seong J, Hunter NR, Buchmiller L, Mason K, Milas L.
    Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):413-9. PubMed ID: 10760438
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.
    Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, McClanahan T, Black S, Rizzi G, Musco ML, Mirza A, Liu S.
    J Biol Chem; 2002 Sep 27; 277(39):36329-37. PubMed ID: 12138103
    [Abstract] [Full Text] [Related]

  • 20. Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells.
    Bhatt M, Ivan C, Xie X, Siddik ZH.
    Oncotarget; 2017 Feb 14; 8(7):10905-10918. PubMed ID: 28038466
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 56.